W e present a rare case of fulminant myocarditis caused by a cytomegalovirus (CMV) infection in an immunocompetent patient-an infection that oral valganciclovir therapy resolved in a dramatic clinical and immunologic manner. Cytomegalovirus infection occurs primarily in the setting of advanced immunosuppression (for example, among human immunodeficiency virus [HIV] patients and organ-transplant recipients) and is typically a reactivation of latent infection. Cytomegalovirus infection in an immunocompetent host is generally asymptomatic; or it might present as a mild, self-limiting, heterophile-negative, mononucleosis-like syndrome. Occasionally, primary CMV infection in immunocompetent hosts can lead to severe organ-specific complications, significant morbidity, and death.1 In a 2008 review 2 of the medical literature, which examined 290 immunocompetent adults with severe CMV infection, the most frequent sites involved were the gastrointestinal tract (colitis) and the central nervous system (meningitis, encephalitis, and transverse myelitis), followed by the blood (hemolytic anemia and thrombocytopenia), the arterial or venous system (thrombosis), the eyes (uveitis), and the lungs (pneumonitis). In contrast, CMV myocarditis and pericarditis in an immunocompetent host are extremely rare entities: few cases have been reported to date. [3][4][5][6][7][8][9][10][11][12][13] It is quite possible that the true number of CMV myocarditis cases is underreported, because most cases are self limiting and underdiagnosed.
Case ReportIn January 2013, a 72-year-old previously healthy white woman was hospitalized for high-grade fevers (2-week history) unresponsive to acetaminophen and for profound weakness, myalgia, headaches, and poor oral intake. She reported no recent contact with sick people or animals, no recent history of travel, no history of blood-product transfusion, and no smoking, alcohol, or recreational drug use. Her medical history was significant for hypothyroidism treated with levothyroxine. Examination at presentation was unexceptional apart from high-grade fevers up to 104 °F.Her initial laboratory studies showed a white blood cell count of 7.6 ×10 3 /µL (normal range, 4-11 ×10 3 /µL) with a lymphocyte count of 66% (normal range, 20%-53%). Her C-reactive protein level was 11 mg/dL (normal, ≤0.49 mg/dL). Her liver enzymes on admission were elevated: alkaline phosphatase, 201 U/L (normal range, 20-140 U/L); aspartate aminotransferase, 171 U/L (normal range, 5-40 U/L); and alanine aminotransferase, 162 U/L (normal range, 5-40 U/L). Her bilirubin lev-